• DOI:10.3109/00498254.2015.1136989
Corpus ID: 34603935

Pharmacokinetics, metabolism, and excretion of nefopam, a dual reuptake inhibitor in healthy male volunteers

@article{Sanga2016PharmacokineticsMA,
  title={Pharmacokinetics, metabolism, and excretion of nefopam, a dual reuptake inhibitor in healthy male volunteers},
  author={Madhu Sanga and John Banach and A. Ledvina and N. Modi and Aravind Mittur},
  journal={Xenobiotica},
  year={2016},
  volume={46},
  pages={1001 - 1016}
}

Madhu Sanga, John Banach, +2 authors Aravind Mittur

Published 2016

Chemistry, Medicine

Xenobiotica

Abstract 1. The disposition of nefopam, a serotonin–norepinephrine reuptake inhibitor, was characterized in eight healthy male volunteers following a single oral dose of 75 mg [14C]-nefopam (100 μCi). Blood, urine, and feces were sampled for 168 h post-dose. 2. Mean (± SD) maximum blood and plasma radioactivity concentrations were 359 ± 34.2 and 638 ± 64.7 ngEq free base/g, respectively, at 2 h post-dose. Recovery of radioactive dose was complete (mean 92.6%); a mean of 79.3% and 13.4% of the… CONTINUE READING

View on Taylor & Francis

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed